Welcome to our dedicated page for Valens Semiconductor SEC filings (Ticker: VLN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Valens Semiconductor Ltd. (NYSE: VLN) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as a foreign private issuer. Valens files annual reports on Form 20-F and current reports on Form 6-K with the U.S. Securities and Exchange Commission, covering financial statements, earnings releases, shareholder meeting materials, and key corporate announcements.
Recent Form 6-K filings include press releases about MIPI A-PHY-based automotive design wins, machine vision platforms, e-mirror solutions, participation in investor conferences, and meetings at major industry events such as CES. Other 6-K filings furnish condensed consolidated financial statements, earnings releases, and information related to the company’s annual general meeting of shareholders, including proxy statements and voting results.
Through this page, users can follow how Valens reports topics such as its business segments, risk factors, capital markets activity, and governance matters. Filings also reference incorporation into registration statements on Form F-3 and Form S-8, reflecting how specific disclosures are used in securities offerings and equity compensation plans.
Stock Titan enhances these documents with AI-powered summaries that explain the key points of lengthy filings, helping readers quickly understand the main developments in each report. Real-time updates from EDGAR ensure that new 6-K and 20-F submissions for VLN are available as they are filed. Users can review these filings to analyze Valens Semiconductor’s financial reporting, regulatory communications, and other material information relevant to VLN stock.
A holder of VLN ordinary shares has filed a Rule 144 notice to sell 33,000 shares through Oppenheimer & Co. Inc. on or about 02/06/2026 on the NYSE, with an aggregate market value of $47,190.00. The issuer has 106,342,415 shares outstanding.
The 33,000 shares were acquired on 06/01/2017 under an Employee Stock Option Plan, from the issuer, with payment in cash upon exercise on 02/06/2026. Over the prior three months, the same seller, Dror Jerushalmi, completed multiple open‑market sales of ordinary shares, including 139,431 shares on 01/09/2026 for $249,791.27.
An insider of VLN has filed a notice of intent to sell 31,050 ordinary shares on the NYSE through Oppenheimer & Co. Inc., with an indicated aggregate market value of $47,817. The filing notes that 106,342,415 shares of this class were outstanding and lists an approximate sale date of February 5, 2026.
The shares to be sold were acquired on June 1, 2017 under an employee stock option plan from the issuer, with cash payment upon exercise dated February 5, 2026. The reporting person, Dror Jerushalmi, also reports multiple prior sales of ordinary shares over the last three months, with individual transactions ranging from 6,000 to 139,431 shares.
An affiliate of VLN, identified as Dror Jerushalmi, has filed a Form 144 notice to sell 30,000 ordinary shares through Oppenheimer & Co. Inc. on the NYSE, with an aggregate market value of 51,000.00 and an approximate sale date of 02/02/2026. The filing notes that there were 106,342,415 ordinary shares outstanding at the time of the notice.
The 30,000 shares to be sold come from employee stock option plan grants acquired on 06/01/2017 and 01/11/2019, with 15,000 shares from each grant to be exercised and paid in cash on 02/02/2026. The notice also lists prior sales in the last three months by the same seller, including a sale of 139,431 ordinary shares on 01/09/2026 for gross proceeds of 249,791.27.
Valens Semiconductor announced an operational efficiency plan that includes reducing its workforce by about 10% across various departments. The company expects this restructuring to lower annual operating expenses by roughly $5 million, aiming to focus resources on business areas showing the strongest momentum while preserving a solid financial position.
Management emphasized that, despite recent revenue growth, the plan is intended to optimize the cost structure and concentrate on core segments with significant growth opportunities. Valens stated it is committed to supporting affected employees. The company also plans to release its fourth quarter and full year 2025 financial results and host a conference call on February 25, 2026.
A holder of VLN ordinary shares has filed a Rule 144 notice to sell 42,017 shares through Oppenheimer & Co. on the NYSE, with an aggregate market value of $87,815.53. These shares were acquired from the issuer as RSUs on 01/15/2024.
The notice also lists prior sales in the last three months by Kishon Eyal, including 338,090 ordinary shares sold on 01/09/2026 for $651,431.81 and 29,412 shares sold on 01/12/2026 for $72,941.76. The filing states that the seller represents they are not aware of undisclosed material adverse information about the issuer.
Valens Semiconductor shareholder files notice to sell shares. A holder has filed a Form 144 indicating an intention to sell 10,000 ordinary shares of Valens Semiconductor on the NYSE through Oppenheimer & Co. Inc., with an aggregate market value of 23,100.00 and 106,342,415 shares outstanding.
The shares to be sold were acquired on 06/01/2017 through an employee stock option plan from the issuer, with cash payment upon exercise dated 01/13/2026. The notice also lists several prior sales of ordinary shares by Dror Jerushalmi over the past three months, including multiple transactions in December 2025 and January 2026 with disclosed gross proceeds for each trade.
Valens Semiconductor (VLN) insider Kishon Eyal has filed a notice of proposed sale of company stock. The filing covers 29,412 ordinary shares to be sold through Oppenheimer & Co. Inc. on the NYSE, with an aggregate market value of $72,941.76, based on the price used in the notice. The filing states that 106,342,415 ordinary shares were outstanding.
The shares to be sold were acquired from the issuer as restricted stock units (RSUs), split between 14,706 shares acquired on 01/15/2022 and 14,706 shares acquired on 01/15/2023. The notice also reports that Eyal sold 338,090 ordinary shares on 01/09/2026 for gross proceeds of $651,431.81. The filer represents that he is not aware of any undisclosed material adverse information about the issuer.
This Form 144 notice states that holder Dror Jerushalmi intends to sell 20,000 ordinary shares of issuer VLN through Oppenheimer & Co. Inc. on the NYSE, with an aggregate market value of $46,200.00. The issuer has 106,342,415 ordinary shares outstanding.
The 20,000 shares to be sold were acquired on 06/01/2017 under an Employee Stock Option Plan from the issuer and are to be paid for in cash upon exercise on 01/12/2026.
Over the past three months, the same seller reported multiple sales of ordinary shares, including 24,000 shares on 12/05/2025 for $40,800.00 and 139,431 shares on 01/09/2026 for $249,791.27. By signing, the seller represents that they are not aware of undisclosed material adverse information about the issuer’s operations.
A shareholder of VLN has filed a Rule 144 notice to sell 139,431 ordinary shares through Oppenheimer & Co. Inc. on the NYSE, with an approximate sale date of 01/09/2026 and an indicated aggregate market value of 217,512.36. The filing notes that 106,342,415 ordinary shares of the issuer are outstanding.
The shares to be sold were acquired on 06/01/2017 under an Employee Stock Option Plan from the issuer, with the purchase price to be paid in cash upon exercise dated 01/09/2026. The notice also lists prior sales over the past three months by the same seller, including 24,000 shares on 12/05/2025 for gross proceeds of 40,800.00 and 58,900 shares on 01/02/2026 for gross proceeds of 90,906.92.
An affiliate of VLN has filed a notice to sell ordinary shares under Rule 144. The filing covers 20,000 ordinary shares, to be sold through Oppenheimer & Co. Inc. on the NYSE, with an aggregate market value of $37,440.00. These shares were acquired on 06/09/2021 through an employee stock options plan and are scheduled to be paid for in cash upon exercise on 01/09/2026.
The notice also lists recent activity by the same seller, who sold 2,868 ordinary shares on 10/14/2025 for gross proceeds of $5,288.88 and a further 1,132 ordinary shares on 10/15/2025 for gross proceeds of $2,087.52. The issuer had 106,342,415 ordinary shares outstanding at the time referenced, providing context for the size of these planned and recent sales.